Galectin Therapeutics (GALT) Common Equity (2010 - 2026)
Galectin Therapeutics (GALT) reported Common Equity of -$138.58 million for Q2 2026, compared with -$118.89 million a year earlier.
Powered by 
Analysis
Galectin Therapeutics (GALT) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics posted Common Equity of -$127.92 million.
- By year, Common Equity came in at -$104.79 million in FY2024, -$61.96 million in FY2023, -$33.92 million in FY2022 and $893,000 in FY2021 (-96.0%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity in data going back to Q4 2010.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$131.96 million (Q1 2026), -$127.92 million (Q4 2025) and -$125.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Galectin Therapeutics | 260.61 Mn | 260.61 Mn | - | -138.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -138.58 Mn |
| Mar 31, 2026 | -131.96 Mn |
| Dec 31, 2025 | -127.92 Mn |
| Sep 30, 2025 | -125.30 Mn |
| Jun 30, 2025 | -118.89 Mn |
| Mar 31, 2025 | -113.98 Mn |
| Dec 31, 2024 | -104.79 Mn |
| Sep 30, 2024 | -94.20 Mn |
| Jun 30, 2024 | -83.87 Mn |
| Mar 31, 2024 | -44.37 Mn |
| Dec 31, 2023 | -61.96 Mn |
| Sep 30, 2023 | -52.60 Mn |
| Jun 30, 2023 | -52.85 Mn |
| Mar 31, 2023 | -44.37 Mn |
| Dec 31, 2022 | -33.92 Mn |
| Sep 30, 2022 | -24.06 Mn |
| Jun 30, 2022 | -16.95 Mn |
| Mar 31, 2022 | -7.92 Mn |
| Dec 31, 2021 | 893,000.00 |
| Sep 30, 2021 | 7.53 Mn |
API Access
Galectin Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();